Kate has been in industry for over 20 years, and currently works at Intellia Therapeutics in Cambridge, Massachusetts as the head of TMF. Kate implemented eTMF systems at both Alkermes and bluebird bio and is currently assessing vendors for eTMF implementation at Intellia. Her focus is finding a system and creating efficient processes that don’t overburden the internal team and leverage the CRO where possible.
Complete the short form below to register for FREE. All fields indicated with an * are required.